company tower banner
Frau Pharma Company Logo

Frau Pharma Fenfluramine

Frau Pharma Fenfluramine is developed initially to treat obesity, Fenfluramine is currently undergoing Phase III clinical trials as an anticonvulsant agent to treat refractory generalized tonic-clonic seizures in Dravet syndrome.

Functions: Anti-Convulsant, Supplement